| Online-Ressource |
Verfasst von: | Jantunen, Esa [VerfasserIn]  |
| Boumendil, Ariane [VerfasserIn]  |
| Finel, Herve [VerfasserIn]  |
| Luan, Jian-Jian [VerfasserIn]  |
| Johnson, Peter [VerfasserIn]  |
| Rambaldi, Alessandro [VerfasserIn]  |
| Haynes, Andrew [VerfasserIn]  |
| Duchosal, Michel A. [VerfasserIn]  |
| Bethge, Wolfgang [VerfasserIn]  |
| Biron, Pierre [VerfasserIn]  |
| Carlson, Kristina [VerfasserIn]  |
| Craddock, Charles [VerfasserIn]  |
| Rudin, Claudius [VerfasserIn]  |
| Finke, Jurgen [VerfasserIn]  |
| Salles, Gilles [VerfasserIn]  |
| Kroschinsky, Frank [VerfasserIn]  |
| Sureda, Anna [VerfasserIn]  |
| Dreger, Peter [VerfasserIn]  |
Titel: | Autologous stem cell transplantation for enteropathy-associated T-cell lymphoma |
Titelzusatz: | a retrospective study by the EBMT : brief report |
Verf.angabe: | Esa Jantunen, Ariane Boumendil, Herve Finel, Jian-Jian Luan, Peter Johnson, Alessandro Rambaldi, Andrew Haynes, Michel A. Duchosal, Wolfgang Bethge, Pierre Biron, Kristina Carlson, Charles Craddock, Claudius Rudin, Jurgen Finke, Gilles Salles, Frank Kroschinsky, Anna Sureda, and Peter Dreger, on behalf of the Lymphoma Working Party of the EBMT |
E-Jahr: | 2013 |
Jahr: | January 29, 2013 |
Umfang: | 4 S. |
Teil: | volume:121 |
| year:2013 |
| number:13 |
| pages:2529-2532 |
| extent:4 |
Fussnoten: | Gesehen am 25.03.2021 |
Titel Quelle: | Enthalten in: Blood |
Ort Quelle: | Washington, DC : American Society of Hematology, 1946 |
Jahr Quelle: | 2013 |
Band/Heft Quelle: | 121(2013), 13, Seite 2529-2532 |
ISSN Quelle: | 1528-0020 |
Abstract: | Enteropathy-associated T-cell lymphoma (EATL) is a rare subtype of peripheral T-cell lymphomas with a poor prognosis. Autologous stem cell transplantation (ASCT) was retrospectively evaluated as a consolidation or salvage strategy for EATL. The analysis included 44 patients who received ASCT for EATL between 2000 and 2010. Thirty-one patients (70%) were in first complete or partial remission at the time of the ASCT. With a median follow-up of 46 months, relapse incidence, progression-free survival, and overall survival were 39%, 54%, and 59% at 4 years, respectively, with only one relapse occurring beyond 18 months posttransplant. There was a trend for better survival in patients transplanted in first complete or partial remission at 4 years (66% vs 36%; P = .062). ASCT is feasible in selected patients with EATL and can yield durable disease control in a significant proportion of the patients. |
DOI: | doi:10.1182/blood-2012-11-466839 |
URL: | Bitte beachten Sie: Dies ist ein Bibliographieeintrag. Ein Volltextzugriff für Mitglieder der Universität besteht hier nur, falls für die entsprechende Zeitschrift/den entsprechenden Sammelband ein Abonnement besteht oder es sich um einen OpenAccess-Titel handelt.
Volltext: https://doi.org/10.1182/blood-2012-11-466839 |
| DOI: https://doi.org/10.1182/blood-2012-11-466839 |
Datenträger: | Online-Ressource |
Sprache: | eng |
K10plus-PPN: | 1752430476 |
Verknüpfungen: | → Zeitschrift |
Autologous stem cell transplantation for enteropathy-associated T-cell lymphoma / Jantunen, Esa [VerfasserIn]; January 29, 2013 (Online-Ressource)